Skip to Main Content

Paper Details

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer.
Eur Urol Oncol
1
2023
Aggressive Prostate Cancer, B1, BRCA2, BRCA2 P/LP, Cancer, E2F, G84E, G84E), HOXB13, HOXB13 (, HOXB13 (G84E), HOXB13 (X285K), HOXB13 (X285K) variant, HOXB13 Variant, HOXB13 variant, MYC, RNA, X285K, X285K protein, X285K), androgen, c-Myc, cell-line, cyclin, cyclin B1, enhancers, men, patient, patients, promoters, prostate cancer, single cell line, wild-type HOXB13 protein
Author NameAffiliation
Sarah M NielsenInvitae Corporation
Edward D EsplinInvitae Corporation
Edward D EsplinInvitae Corporation
Emmanuel S AntonarakisMasonic Cancer Center, University of Minnesota
  • 1 - 4

Datasets

Release 1.2